Prescription Justice
BLOG POSTS

04
Aug
2020

Americans Need to Hold the U.S. Congress Accountable for the World’s Highest Drug Prices.

While the coronavirus pandemic is the most pernicious public health crisis of our time, for decades now the crisis of high drug prices is a ubiquitous feature of the American healthcare landscape. Young adults dying because they can’t afford insulin; people burdened with battling cancer facing bankruptcy due to the price of cancer drugs; patients going to the emergency rooms because they did not take heart medications due to cost; parents faced with the decision of whether or not they can afford a new Epipen, as their old one faces expiration, and the list goes on and on. We are outraged by the greed of the pharmaceutical industry, but we cannot vote in and out of office their CEOs and other executives. But we can do just that when it comes to Congress. To help, Prescription Justice has created the Drug Prices Congressional Report Card in which we have graded all members of the U.S. Congress, House and Senate, on their action or inaction on drug prices.

10
Mar
2020

Prescription Justice President Submitted Comments to the Food and Drug Administration Regarding Section 804 Importation of Prescription Drugs

Gabriel Levitt, President of Prescription Justice submitted comments to the Food and Drug Administration (FDA) in response to the Notice of Proposed Rulemaking (NPRM) titled "Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. Reg. 70796.

31
Dec
2019

Prescription Justice President’s Statement Becomes Part of the Congressional Record

Prescription Justice is proud to announce that a statement prepared by PJ President Gabriel Levitt for the U.S. House Ways and Means Committee on “Investing In The U.S. Health System By Lowering Drug Prices, Reducing, Out-of-Pocket Costs and Improving the Medicare Benefit” is now part of the official congressional record.

23
Dec
2019

Prescription Justice President Pens Op Ed for The New York Daily News

The New York Daily News recently published the Op-Ed United we stand, at least on drug prices by Prescription Justice President, Gabriel Levitt. Mr. Levitt’s Op-Ed underscores the fact that while there is little consensus among voters from different political parties, there is one stark exception: prescription drug prices.

24
Sep
2019

FDA Destroys Elizabeth’s Personal Drug Import

Elizabeth, who is from California, periodically gets migraine headaches. To treat them, she is prescribed brand name Relpax (elitriptan), but finds that the drug is too expensive in the U.S., so she chooses to import the same drug at a much lower price. Despite federal restrictions, most medicines that are imported for personal use reach the patient. But not always. In Elizabeth’s case, instead of receiving her medication, the Food and Drug Administration (FDA) destroyed the medication after it was detained at an international mail facility (IMF). She gave Prescription Justice the green light to tell her story.